View Author

Hillis, W.S.

( W.S. Hillis)


patient infusion rt-pa 1 patient reocclusion 24 hours group infarction angiogram vessel infarct-related placebo artery reocclusion rate patent minute randomized study 90 minutes streptokinase occlusion rt-pa infusion catheterization confidence angiography patent infarct-related artery thrombolysi 3 patients infarct-related artery blood range assessment trial patency 2 patients interval myocordial infarction placebo group limit hospital blood samples 6 hours intracoronary streptokinase 5 patients hospital discharge randomized trial analysis tissue-type plasminogen activator discharge rt-pa group infarct-related vessel fibrinogen subtotal occlusion perforation intracoronary activator recanalization angioplasty lubsen grade coagulation tissue-type serruy center subtotal patent infarct-related vessel stenosi tissue-type plosminogen activator heart meyer j circulation mathey maintenance infusion enzyme angiography evaluation group complication table 1 st angio lubsen j 24- hour angiogram




1 Most Recent Publications

Acute coronary thrombolysis with recombinant human tissue-type plasminogen activator: initial patency and influence of maintained infusion on reocclusion rate (Article)
Verstraete, M. Brower, R.W. Reid, D.S. Rutsch, W.R. Schartl, M. Schofer, J. Serruys, P.W.J.C. Simoons, M.L. Uebis, R. Vahanian, A. Verheugt, F.W.A. Essen, R. von Collen, D. Arnold, A.E.R. Bone, D.P. de Zwaan, C. de Erbel, R. Hillis, W.S. Lennane, R.J. Lubsen, J. Mathey, D.
1987-01-01